文献速递骨质疏松与代谢性骨病脊柱外科

长期服用抗癫痫药且骨密度正常的癫痫患者椎体骨折高发

High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.
PubMed 文献 · Osteoporos Int · 2021-04-06

本研究纳入146名长期使用抗癫痫药的男性退伍军人癫痫患者,在同次DXA检查中行椎体骨折评估。结果显示骨密度正常者中41%存在至少一处椎体骨折,骨量减少者为54%,骨质疏松者为75%,提示仅凭骨密度会漏诊大量椎体骨折。

要点

  • 长期抗癫痫药的癫痫患者中,骨密度正常者41%仍存在椎体骨折。
  • 骨量减少和骨质疏松者椎体骨折比例分别达54%和75%。
  • 建议此类患者骨健康评估中加做椎体骨折评估以指导治疗。

核心结论

  • 长期使用抗癫痫药的癫痫患者中,即使骨密度正常或仅骨量减少,椎体压缩骨折的患病率仍很高。
  • 在标准骨密度检查基础上加做椎体骨折评估可发现大量被漏诊的椎体骨折。

研究设计与样本

  • 回顾性队列研究,纳入146名长期使用抗癫痫药(至少2年)的男性退伍军人癫痫患者。
  • 所有受试者均在同次DXA检查中按标准椎体骨折评估方案完成形态学评估。

主要发现

  • 受试者平均年龄63岁,骨量减少者占43%,骨质疏松者占29%。
  • 骨密度正常者中41%存在至少一处椎体骨折。
  • 骨量减少者中54%存在至少一处椎体骨折,骨质疏松者中为75%。

关键数值与推荐

  • 长期抗癫痫药定义为持续使用苯巴比妥、苯妥英、卡马西平、扑米酮或丙戊酸至少2年。
  • 骨密度分类采用骨质疏松或骨量减少标准,椎体骨折通过DXA同次检查的椎体骨折评估判定。

临床怎么用

  • 对长期服用抗癫痫药的癫痫患者,骨健康评估应包含椎体骨折评估或其他影像方法。
  • 即使骨密度正常或仅骨量减少,也应关注椎体骨折风险以调整预防治疗建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: People with epilepsy who take certain medications are at risk for developing osteoporosis and fractures of the vertebrae that commonly go undiagnosed. By using technology available in a bone density scan, we observed at least one fracture in many subjects with bone density in the normal and osteopenic range. PURPOSE/INTRODUCTION: Chronic use of antiepileptic drugs (AEDs), both enzyme-inducing (phenytoin, phenobarbital, carbamazepine, and primidone) and non-enzyme-inducing (i.e., valproate), is recognized as a cause of secondary osteoporosis. Vertebral compression fractures (VF) are the most common type of osteoporotic fractures and may confer an increased risk of future hip, wrist, and vertebral fractures. Vertebral compression fractures in the general population are frequently asymptomatic, and under-diagnosed. The purpose of this study is to describe the prevalence of VF in a cohort of male veterans with epilepsy on chronic AEDs. METHODS: The cohort for this study consisted of 146 male veterans who carried a diagnosis of epilepsy and were chronic users of AEDs known to cause osteoporosis (phenobarbital, phenytoin, carbamazepine, primidone, and valproate). Chronic AED use was defined as receiving an AED for at least 2 years. Subjects were previously seen in the osteoporosis clinic and had been evaluated by a dual-energy X-Ray absormetry (DXA) instrument including morphometric studies following a standard vertebral fracture assessment (VFA) protocol during the same DXA imaging acquisition session. RESULTS: The mean age was 63 years. Low bone mineral density defined as osteoporosis or osteopenia was observed in 29% and 43% respectively. We observed at least one VF in 41 % of the subjects who had normal BMD, 54% in the osteopenic range, and 75% in the osteoporotic range. CONCLUSIONS: By performing a VFA in addition to standard bone densitometric studies, we disclosed a large prevalence of compression fractures in individuals with epilepsy chronically treated with AEDs who had BMDs in the normal and osteopenic ranges. The addition of VFA or other imaging methods to evaluate VF should be included in the evaluation of bone health in individuals with epilepsy receiving AEDs since it may modify treatment recommendations to prevent future osteoporotic fractures.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Dussault PM, McCarthy D, Davis SA, et al. High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs. Osteoporos Int. 2021. PMID: 33822290. doi:10.1007/s00198-021-05926-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。